Monday, September 19, 2011

Bristol Myers a takeout candidate???

Jefferies upgrades Bristol Myers (BMY) to Buy and increases its price target on shares to $35 from $27. The firm sees Bristol's underlying revenue and EPS ready to "rapidly take off mid-term," positioning the company as a "prime target for acquisition."
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)